These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical manifestations and specific features of the course of adenogenic tuberculosis in adults]. Ozerova LV; Zaĭtseva IP; Chistiakova NA Probl Tuberk; 2003; (3):42-5. PubMed ID: 12744064 [TBL] [Abstract][Full Text] [Related]
4. [Follow-up of antitubercular treatment]. Gavira R; Gómez F; Otero MJ; Barrueco M; Domínguez-Gil A Rev Clin Esp; 1994 Sep; 194(9):677-81. PubMed ID: 7984795 [TBL] [Abstract][Full Text] [Related]
5. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism]. Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
7. [Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy]. Onaka A Kekkaku; 1987 Dec; 62(12):672-5. PubMed ID: 3448353 [No Abstract] [Full Text] [Related]
8. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents]. Gergert VIa; Rusakova LI Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056 [TBL] [Abstract][Full Text] [Related]
9. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis]. Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)]. Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917 [No Abstract] [Full Text] [Related]
12. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens. Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224 [TBL] [Abstract][Full Text] [Related]
13. [The use of plasmapheresis in treating the broncho-obstructive syndrome in patients with pulmonary tuberculosis]. Shmelev EI; Draganiuk AK Probl Tuberk; 1992; (11-12):39-42. PubMed ID: 1289886 [TBL] [Abstract][Full Text] [Related]
14. [Adverse reactions of antituberculous agents, especially about its onset and duration]. Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434 [TBL] [Abstract][Full Text] [Related]
15. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs]. Mishin VIu; Vasil'eva IA; Makieva VG; Kuz'mina NV; Prikazchikova AV; Khoroshutina VV Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872 [TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria]. Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553 [TBL] [Abstract][Full Text] [Related]
18. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs]. Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874 [No Abstract] [Full Text] [Related]
19. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs]. Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643 [TBL] [Abstract][Full Text] [Related]
20. [EFFERENT THERAPY IN THE TREATMENT OF PATIENTS WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS]. Tuberk Biolezni Legkih; 2010; (3):28-33. PubMed ID: 27529955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]